Over 100+ units preordered within days of launch.
First production batch already in progress.
Demand validated through direct-to-consumer sales and paid acquisition.
Early customers across multiple countries.

bioverà is building the first upstream respiratory intelligence platform.
We have already validated the core technology, completed early prototypes, and secured initial customer demand through preorders.
We are now preparing for large-scale manufacturing and global distribution.
We are actively seeking strategic investors
bioverà is opening a limited investment round.
We are seeking strategic investors and partners.
Investment details available upon request. Limited allocation available.
biovera.ai
Copyright © 2026 biovera.ai - All Rights Reserved.
Content on site does not constitute medical advice